Stromal CYR61 Confers Resistance to Mitoxantrone via Spleen Tyrosine Kinase Activation in Human Acute Myeloid Leukaemia

• Published in: British journal of haematology Vol. 170; no. 5; pp. 704 - 718
• Main Authors: Long, Xin, Yu, Yang, Perlaky, Laszlo, Man, Tsz‐Kwong, Redell, Michele S.
• Format: Journal Article
• Language: English
• Published: England 01.09.2015
• Subjects: adhesion; Antineoplastic Agents - pharmacology; Cell Line, Tumor; Cysteine-Rich Protein 61 - biosynthesis; drug resistance; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Leukemic - drug effects; Humans; Intracellular Signaling Peptides and Proteins - metabolism; Leukemia, Myeloid, Acute - drug therapy; Leukemia, Myeloid, Acute - metabolism; Leukemia, Myeloid, Acute - pathology; Male; marrow stroma; Mitoxantrone - pharmacology; myeloid leukaemia; Neoplasm Proteins - metabolism; Protein-Tyrosine Kinases - metabolism; Signal Transduction; signalling; Stromal Cells - metabolism; Stromal Cells - pathology; Syk Kinase; Up-Regulation - drug effects; myeloid leukaemia; adhesion; drug resistance; marrow stroma; signalling
• ISSN: 0007-1048; 1365-2141
• DOI: 10.1111/bjh.13492

Summary Approximately 50% of children with acute myeloid leukaemia (AML) relapse, despite aggressive chemotherapy. The bone marrow stromal environment protects leukaemia cells from chemotherapy (i.e., stroma‐induced chemoresistance), eventually leading to recurrence. Our goal is to delineate the mechanisms underlying stroma‐mediated chemoresistance in AML. We used two human bone marrow stromal cell lines, HS‐5 and HS‐27A, which are equally effective in protecting AML cells from chemotherapy‐induced apoptosis in AML‐stromal co‐cultures. We found that CYR61 was highly expressed by stromal cells, and was upregulated in AML cells by both stromal cell lines. CYR61 is a secreted matricellular protein and is associated with cell‐intrinsic chemoresistance in other malignancies. Here, we show that blocking stromal CYR61 activity, by neutralization or RNAi, increased mitoxantrone‐induced apoptosis in AML cells in AML‐stromal co‐cultures, providing functional evidence for its role in stroma‐mediated chemoresistance. Further, we found that spleen tyrosine kinase (SYK) mediates CYR61 signalling. Exposure to stroma increased SYK expression and activation in AML cells, and this increase required CYR61. SYK inhibition reduced stroma‐dependent mitoxantrone resistance in the presence of CYR61, but not in its absence. Therefore, SYK is downstream of CYR61 and contributes to CYR61‐mediated mitoxantrone resistance. The CYR61‐SYK pathway represents a potential target for reducing stroma‐induced chemoresistance.